Jane Street Group, LLC Cel Sci Corp Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$7.1 - $12.82 $71,710 - $129,482	-10,100 Reduced 4.03%	240,700 $1.71 Million
Q3 2021 Nov 16, 2021	SELL	$7.64 - $12.49 $1.88 Million - $3.07 Million	-245,600 Reduced 49.48%	250,800 $2.76 Million
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $4.54 Million - $14.4 Million	-522,800 Reduced 51.3%	496,400 $4.31 Million
Q1 2021 May 18, 2021	BUY	$12.0 - $27.64 $8.88 Million - $20.5 Million	740,100 Added 265.17%	1,019,200 $15.5 Million
Q4 2020 Feb 17, 2021	BUY	$11.05 - $16.62 $832,065 - $1.25 Million	75,300 Added 36.95%	279,100 $3.25 Million
Q3 2020 Nov 17, 2020	BUY	$11.69 - $14.54 $489,811 - $609,226	41,900 Added 25.88%	203,800 $2.6 Million
Q2 2020 Aug 17, 2020	BUY	$9.75 - $17.6 $1.14 Million - $2.07 Million	117,400 Added 263.82%	161,900 $2.42 Million
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $335,530 - $758,725	44,500 New	44,500 $514,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.